Andrew Moore, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Main St, Augusta, AR 72006 Phone: 870-347-2620 Fax: 870-347-2624 |
Amanda Renee Rigsby Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Highway 64 E, Augusta, AR 72006 Phone: 870-347-2534 Fax: 870-347-2023 |
Ashlyn Kay Curry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 304 Highway 64 E, Augusta, AR 72006 Phone: 870-347-2620 |
News Archive
Experts who reviewed the terminology associated with genitourinary tract symptoms related to menopause-currently referred to as vulvovaginal atrophy-have agreed that the term genitourinary syndrome of menopause (GSM) is a medically more accurate, all-encompassing, and a more publicly acceptable term.
The EU- and industry-funded RTCURE project's groundbreaking approach promises to revolutionise treatment of rheumatoid arthritis, which afflicts millions of people across Europe with joint pain, inflammation and bone and cartilage loss.
CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer.
› Verified 9 days ago